OVERVIEW: In the article named "Is Valeant Pharmaceauticals the Next Enron?", Nocera explains the history of Valeant Pharmaceuticals.
SOAPSTONE: The subject is Valeant Pharmaceuticals. The speaker is Joe Nocera. He wrote this article because of its recent investigations. The audience are medical consumers. The purpose of this article is to show the readers that Valeant Pharmaceuticals is a sketchy company. The tone is ironic; he compares Valeant to Enron (a company that has gone downhill). LOGICAL FALLACY: Slippery Slope is used in this article. Nocera explains that if Valeant Pharmaceauticals continues to go down this road, it will end up like Enron. |
My annotations can be found below.
|